Sk. Pruitt et al., THE EFFECT OF XENOREACTIVE ANTIBODY AND B-CELL DEPLETION ON HYPERACUTE REJECTION OF GUINEA-PIG-TO-RAT CARDIAC XENOGRAFTS, Transplantation, 56(6), 1993, pp. 1318-1324
Xenotransplantation between phylogenetically distant species is preven
ted by hyperacute rejection (HAR), a process that is thought to be ini
tiated by the binding of naturally occurring xenoreactive antibodies (
NAb) to the endothelium of the xenograft (Xg) with subsequent activati
on of the classical pathway of C. The relative role of direct alternat
ive pathway C activation in HAR is controversial. To evaluate the role
of NAb in HAR of discordant rodent Xg, LEW rats were treated from the
day of birth with i.p. injections of rabbit anti-rat IgM antiserum (R
ARM), or with mAb specific for rat kappa-light chain (OX12) or rat cla
ss II MHC (14-4-4S, Y-3P, or 10-2.16), in an effort to deplete B cells
and NAb. These rats then underwent xenotransplantation with discordan
t guinea pig hearts. RARM was effective in depleting rats (n=5) of B c
ells, serum IgM, and rat NAb directed against guinea pig cells, but gu
inea pig cardiac Xg survival was not prolonged compared with PBS-treat
ed controls (n=5), possibly due to the rabbit NAb specific for guinea
pig cardiac tissue that were passively transferred in the RARM prepara
tion. Of the anti-B cell mAb used to avoid this passive transfer of NA
b, mAb 14-4-4S was highly effective (n=9) in depleting the peripheral
blood and spleen of B cells and the serum of IgM and NAb. Guinea pig c
ardiac Xg survival, however, was again not prolonged (n=5), and reject
ed Xg from the B cell- and NAb-depleted recipients demonstrated rat C3
deposition in the absence of rat IgM and IgG. This study demonstrates
that while neonatal anti-B cell antibody treatment can effectively de
plete B cells and NAb in the rat, such treatment does not significantl
y prolong cardiac Xg survival in this well-established guinea pig to r
at xenotransplantation model. These findings suggest that in addition
to NAb depletion, inhibition of alternative C pathway activation and o
ther humoral mechanisms may be necessary to prevent HAR and allow succ
essful xenotransplantation.